These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11172357)

  • 1. Adjuvant interferon for hepatocellular carcinoma.
    Okada S; Sato T; Yamamoto S
    Hepatology; 2001 Feb; 33(2):481-2. PubMed ID: 11172357
    [No Abstract]   [Full Text] [Related]  

  • 2. [Can adjuvant chemotherapy of hepatocellular carcinoma improve results of liver transplantation?].
    Burtin P
    Gastroenterol Clin Biol; 1993; 17(10):776-7. PubMed ID: 8288099
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy and medical treatment of hepatocellular carcinoma (HCC).
    Rougier P; Mitry E; Clavero-Fabri MC
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1264-6. PubMed ID: 9730386
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant treatments for resectable hepatocellular carcinoma.
    Ishii H; Yamamoto J; Ikari T
    J Hepatobiliary Pancreat Surg; 2008; 15(5):459-62. PubMed ID: 18836796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Basic and clinical study of interferon a in hepatocellular carcinoma].
    Sun HC; Wang L; Wu WZ
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1606-8. PubMed ID: 19094750
    [No Abstract]   [Full Text] [Related]  

  • 6. [Liver resection. I].
    Oldhafer KJ; Stavrou GA
    Zentralbl Chir; 2006 Oct; 131(5):W54-66; quiz W67-8. PubMed ID: 17089283
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon for postresection recurrence of hepatocellular carcinoma.
    Mallat DB; El-Serag HB
    Am J Gastroenterol; 2002 Dec; 97(12):3200-2. PubMed ID: 12492213
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of interferon therapy on inhibition of hepatocellular carcinoma development in patients with chronic hepatitis C.
    Shiratori Y; Yoshida H; Omata M
    Jpn J Clin Oncol; 2000 May; 30(5):213-4. PubMed ID: 10857497
    [No Abstract]   [Full Text] [Related]  

  • 9. Receptor-mediated protection of normal hepatocytes during chemotherapy for hepatocellular carcinoma.
    Keegan-Rogers V; Wu CH; Wu GY
    Targeted Diagn Ther; 1991; 4():105-25. PubMed ID: 1665717
    [No Abstract]   [Full Text] [Related]  

  • 10. Can metallothionein be a useful molecular marker for selecting hepatocellular carcinoma patients for platinum-based chemotherapy?
    Doki Y; Monden M
    J Gastroenterol; 2004 Dec; 39(12):1228-9. PubMed ID: 15622495
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical significance of interferon therapy in treatments for hepatitis C virus-related hepatocellular carcinoma].
    Kubo S; Nishiguchi S; Hirohashi K; Tanaka H; Shuto T; Takemura S; Shiomi S; Kinoshita H
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):1975-9. PubMed ID: 11791377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatocellular carcinoma--a chemosensitive tumor?].
    Kubicka S; Malek NP; Zender L
    Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S115-7. PubMed ID: 12817342
    [No Abstract]   [Full Text] [Related]  

  • 13. Polyprenoic acid in hepatocellular carcinoma.
    Decensi A; Costa A
    N Engl J Med; 1996 Nov; 335(19):1461; author reply 1461-2. PubMed ID: 8927082
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of interferon therapy after curative treatment of hepatocellular carcinoma.
    Kudo M
    Oncology; 2008; 75 Suppl 1():30-41. PubMed ID: 19092270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyprenoic acid in hepatocellular carcinoma.
    Yang CH; Cheng AL
    N Engl J Med; 1996 Nov; 335(19):1460-61; author reply 1461-2. PubMed ID: 8927081
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of transarterial chemotherapy after hepatocellular carcinoma resection surgery].
    Zhou QB; Chen RF; Chen JS; Zhou JJ; Lin Q; Wang J
    Zhonghua Gan Zang Bing Za Zhi; 2007 Feb; 15(2):135-6. PubMed ID: 17362642
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy for advanced hepatocellular carcinoma: systemic chemotherapy or hepatic arterial infusion chemotherapy?
    Yamashita T
    J Gastroenterol; 2004; 39(4):404-6. PubMed ID: 15168258
    [No Abstract]   [Full Text] [Related]  

  • 18. Malignant hepatoma.
    van Dyk JJ
    Proc Mine Med Off Assoc SA; 1975; 55(421):19-20. PubMed ID: 209446
    [No Abstract]   [Full Text] [Related]  

  • 19. Sorafenib in hepatocellular carcinoma: separating the hype from the hope.
    Kelley RK; Venook AP
    J Clin Oncol; 2008 Dec; 26(36):5845-8. PubMed ID: 19029408
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma.
    Muto Y; Moriwaki H; Saito A
    N Engl J Med; 1999 Apr; 340(13):1046-7. PubMed ID: 10189289
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.